HIF1A and prostate carcinoma: TRPM7 silencing, however, significantly promoted hypoxia-inducible factor 1 alpha (HIF-1α) degradation through the proteasome and inhibited EMT changes in androgen-independent prostate cancer cells under hypoxic conditions [23].